Nanoform Finland Oyj announced that Niklas Sandler will transition January 1st, 2023, from his role as Chief Technology Officer to technology advisor to the CEO of Nanoform. This coincides with Nanoform's growth strategy moving from an R&D led organization to a commercial and industrial business and Niklas' ambition to become an entrepreneur as founder and Chief Scientific Officer in developing CurifyLabs, which is based on his previous academic research in 3D printing technologies.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.155 EUR | +6.16% | -15.16% | +35.96% |
Apr. 11 | Nanoform Finland to Deliver Nanomedicine Technology to Japan | MT |
Apr. 11 | Nanoform Enters Exclusive Partnership with CBC to Bring Best-In-Class Nanomedicine Technology to Japan | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+35.96% | 197M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- NANOFH Stock
- News Nanoform Finland Oyj
- Nanoform Finland Oyj CTO Niklas Sandler Transitions to Technology Advisor to the CEO, effective, January 1, 2023